SEC Filings | MediWound

Filing date	Form	Description	View
December 23, 2013	DRS	Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy	0000912057-13-000405.pdf 0000912057-13-000405.rtf 0000912057-13-000405.xls View HTML
March 19, 2014	EFFECT	EFFECT	9999999995-14-000697.pdf 9999999995-14-000697.rtf View HTML
March 07, 2016	EFFECT	EFFECT	9999999995-16-003897.pdf 9999999995-16-003897.rtf View HTML
April 22, 2019	EFFECT	EFFECT	9999999995-19-000785.pdf 9999999995-19-000785.rtf View HTML
June 03, 2022	EFFECT	EFFECT	9999999995-22-001688.pdf 9999999995-22-001688.rtf 9999999995-22-001688.xls View HTML
November 25, 2022	EFFECT	EFFECT	9999999995-22-003394.pdf 9999999995-22-003394.rtf 9999999995-22-003394.xls View HTML
April 05, 2023	EFFECT	EFFECT	9999999995-23-000831.pdf 9999999995-23-000831.rtf 9999999995-23-000831.xls View HTML
March 17, 2022	SC 13D	Filing by person(s) reporting owned shares of common stock in a public company >5%	0001193125-22-077905.pdf 0001193125-22-077905.rtf 0001193125-22-077905.xls View HTML
March 21, 2014	424B4	Form of prospectus disclosing information facts events covered in both forms 424B1 424B3	0001047469-14-002744.pdf 0001047469-14-002744.rtf 0001047469-14-002744.xls View HTML
September 19, 2017	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	0001178913-17-002697.pdf 0001178913-17-002697.rtf 0001178913-17-002697.xls View HTML

Data provided by Kaleidoscope.